NCT06680089View on ClinicalTrials.gov

CD70-targeted immunoPET Imaging of Kidney Cancer

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Urologic NeoplasmsUrogenital NeoplasmsKidney NeoplasmsNeoplasms
Interventions
DRUG

[18F]RCCB6

Enrolled patients will receive 0.05-0.1mCi/kg of \[18F\]RCCB6. ImmunoPET/CT imaging will be acquired 1-2 hours after \[18F\]RCCB6 injection.

Trial Locations (1)

200127

RECRUITING

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER